GlassScriptPhysician profile
Marc J Levine
NPI 1316911720
$2,353.66
in general payments reported to CMS, 2019-2025
24 companies · $252 in 2025
The $252 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $228 · 2021: $434 · 2022: $248 · 2023: $504 · 2024: $482 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,238.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $406.04 | 2019-2025 | Nucala |
| Nuvasive, INC. | $385.64 | 2021 | |
| Genzyme Corporation | $251.37 | 2020-2025 | |
| Kaleo, INC. | $187.06 | 2020-2023 | Auvi-Q |
| Astrazeneca Pharmaceuticals LP | $169.49 | 2019-2023 | Fasenra, Tezspire |
| Novartis Pharmaceuticals Corporation | $148.60 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $138.37 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $106.96 | 2020-2024 | Xembify |
| Optinose US, INC. | $106.19 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $65.32 | 2022-2023 | Cuvitru |
| Medtronic, INC. | $63.37 | 2024-2025 | Propel, Stealthstation S8 Platform |
| Stryker Corporation | $57.77 | 2019 | |
| Genentech USA, INC. | $40.34 | 2023-2024 | Xolair |
| Pfizer INC. | $37.49 | 2019-2020 | |
| Ethicon US, LLC | $30.03 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $29.50 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $23.34 | 2025 | Neffy |
| Acclarent, INC | $18.57 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $16.50 | 2020 | |
| Hologic Sales and Service, LLC | $16.35 | 2024 | Coolseal Generator |
| Alk-Abello, INC | $15.14 | 2019 | |
| Hikma Pharmaceuticals USA | $15.10 | 2023 | Ryaltris |
| Glenmark Therapeutics INC. | $14.00 | 2019 | |
| Amgen INC. | $11.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.